EUVIMEDEUVIMED entdecken
Fallbericht

The Homozygous Type II Antithrombin Deficient Pregnant Woman Monitored by Thrombin Generation Assay

Ivana Malikova, Martina Husakova, Jana Bilkova, Radka Brzezkova, Ingrid Hrachovinova, Tomas Kvasnicka

Clinical Laboratory · 2023

DOI: 10.7754/clin.lab.2023.230435 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Laboratory, 2023. Verfasst von Ivana Malikova und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antithrombins, Antithrombin III Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We present the case study of a 28-year-old pregnant woman with antithrombin deficiency who was treated with low-molecular-weight heparin (LMWH). METHODS: Due to severe homozygous type II antithrombin heparin binding site (HBS) deficiency, the thrombin generation (TG) was monitored in this woman via the Thrombin Generation Assay (TGA). We used Siemens diagnostic kits Berichrom® Antithrombin III (IIa) and INNOVANCE® Antithrombin (Xa) to determine antithrombin activity. We used a chromogenic method for determination of factor Xa (FXa) inhibition. RESULTS: There were no thrombotic complications during the whole pregnancy of the observed woman. Antithrombin was administered before and after delivery, which was significantly reflected in the decrease in thrombin generation. CONCLUSIONS: Consistent monitoring of thrombin generation with LMWH anticoagulant therapy administration during pregnancy together with antithrombin administration before and after delivery can improve the overall condition of pregnant women and the quality of their care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntithrombinsAntithrombin III DeficiencyFemaleHumansPregnancyAdultAntithrombin IIIThrombinPregnant PeopleHeparin, Low-Molecular-WeightAnticoagulantsHeparin

Substanzen

AntithrombinsAntithrombin IIIThrombinHeparin, Low-Molecular-WeightAnticoagulantsHeparin

Zitieren

APA

Malikova, I., Husakova, M., Bilkova, J., Brzezkova, R., Hrachovinova, I., & Kvasnicka, T. (2023). The Homozygous Type II Antithrombin Deficient Pregnant Woman Monitored by Thrombin Generation Assay. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2023.230435

Vancouver

Malikova I, Husakova M, Bilkova J, Brzezkova R, Hrachovinova I, Kvasnicka T. The Homozygous Type II Antithrombin Deficient Pregnant Woman Monitored by Thrombin Generation Assay. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2023.230435

BibTeX
@article{Malikova2023,
  author = {Malikova, Ivana and Husakova, Martina and Bilkova, Jana and Brzezkova, Radka and Hrachovinova, Ingrid and Kvasnicka, Tomas},
  title = {The Homozygous Type II Antithrombin Deficient Pregnant Woman Monitored by Thrombin Generation Assay},
  journal = {Clinical Laboratory},
  year = {2023},
  doi = {10.7754/clin.lab.2023.230435}
}
Kostenlos starten →